Loyal portfolio

Vertical Longevity Pharma logo

Vertical Longevity Pharma

Healthcare / Medical / Biomed · USA

PilotUSAFounder InstituteSDG 3SDG 10
David Scieszka

David Scieszka

About Vertical Longevity Pharma

VeLo Pharma is developing the first longevity vaccine to reverse atherosclerosis (clogged arteries), a major driver of heart disease that claims more lives than all cancers combined. By targeting a fundamental hallmark of aging that exists in the vasculature, our vaccine has the added potential to treat multiple age-related diseases simultaneously.

Visit website

In the news

  • Oct 12

    Vertical Longevity Pharmaceuticals presents preliminary primate results from its senolytic vaccine study at Longevity Global.

    View on LinkedIn

Founder

  • David Scieszka

    David Scieszka

Details

Stage
Pilot
Sector
Healthcare / Medical / Biomed, Aging / Longevity
Country
USA
Region
USA
Source
Founder Institute
UN SDGs
SDG 3SDG 10